Fig_2.tif (194.71 kB)

Results of Th17 and Th1 cells.

Download (0 kB)
posted on 28.01.2016 by Ting Lu, Shuang Yu, Yan Liu, Congcong Yin, Jingjing Ye, Zhi Liu, Daoxin Ma, Chunyan Ji

(A) The percentage of circulating Th17 cells was significantly lower in lymphoma patients than normal controls (P = 0.0328). (B) Circulating Th17 cells were decreased significantly in patients with B-NHL (P = 0.0122) compared with NC while there was no significant difference in T-NHL (P = 0.4979) or HL (P = 0.4785). (C) The percentage of circulating Th1 cells was significantly higher in lymphoma patients than normal controls (P = 0.0030). (D) Circulating Th1 cells were statistically increased in patients with B-NHL (P = 0.0026) and T-NHL (P = 0.0008) rather than HL (P = 0.5852) compared to normal controls.* P<0.05; ** P<0.01; *** P<0.001; ns, non-significant